TY - JOUR
T1 - Food protein-induced enterocolitis syndrome in a tertiary pediatric center
T2 - safety of guideline-conforming food challenges
AU - Wong, Samantha
AU - Duan, Lucy
AU - Galper, Alana
AU - Atkinson, Adelle
AU - Upton, Julia
AU - Eiwegger, Thomas
N1 - Funding Information:
TE reports to act as local PI for company sponsored trials by DBV Therapeutics and sub-investigator for Regeneron and ALK. He holds grants from Innovation Fund Denmark, CIHR outside the submitted work. He is co-Investigator or scientific lead in three investigator initiated oral immunotherapy trials supported by the SickKids Food Allergy and Anaphylaxis Program and serves as associate editor for Allergy. He/his lab received unconditional/kind contributions from Macro Array Diagnostics and ALK Abello. He holds advisory board roles for ALK Abello. and Aimmune. JU reports research support/grants from Novartis, Regeneron, ALK, DBV Therapeutics, CIHR, SickKids Food Allergy and Anaphylaxis Program, and fees from Pfizer, ALK Abello, Bausch Health, Kaleo, Food Allergy Canada, all outside the submitted work. SW, LD, AG and AA have no conflicts of interest to declare.
Funding Information:
This study is funded by Food Allergy and Anaphylaxis Program SickKids.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Food protein-induced enterocolitis syndrome is a non-IgE-mediated reaction to food that is poorly understood, and underdiagnosed. Trigger foods can belong to any food group, but are most commonly milk, soy, rice, oat, egg, and fish. In this retrospective study (2015-2020), we describe the clinical presentations and triggers of 37 children referred to tertiary hospital with a confirmed or suspected diagnosis of food protein-inducted enterocolitis. We reviewed the safety of current recommendations by looking at the outcome of 24 oral food challenges. All of these patients presented with clear cut systemic reactions including lethargy. We also assessed the severity of the reactions. Oral food challenges occurred in the hospital day unit with the majority of patients having IV access in place. Despite a clear history of FPIES with lethargy and the requirement for re-hydration of the challenged population, 21/24 (88%) of the FPIES OFCs were successful. Of the three patients who reacted, symptoms were of moderate nature, mainly vomiting. This highlights the importance of early diagnosis and a pro-active approach to performing guideline-directed oral food challenges in patients with food protein-induced enterocolitis syndrome.
AB - Food protein-induced enterocolitis syndrome is a non-IgE-mediated reaction to food that is poorly understood, and underdiagnosed. Trigger foods can belong to any food group, but are most commonly milk, soy, rice, oat, egg, and fish. In this retrospective study (2015-2020), we describe the clinical presentations and triggers of 37 children referred to tertiary hospital with a confirmed or suspected diagnosis of food protein-inducted enterocolitis. We reviewed the safety of current recommendations by looking at the outcome of 24 oral food challenges. All of these patients presented with clear cut systemic reactions including lethargy. We also assessed the severity of the reactions. Oral food challenges occurred in the hospital day unit with the majority of patients having IV access in place. Despite a clear history of FPIES with lethargy and the requirement for re-hydration of the challenged population, 21/24 (88%) of the FPIES OFCs were successful. Of the three patients who reacted, symptoms were of moderate nature, mainly vomiting. This highlights the importance of early diagnosis and a pro-active approach to performing guideline-directed oral food challenges in patients with food protein-induced enterocolitis syndrome.
KW - FPIES
KW - Food allergy
KW - Non-IgE allergy
KW - Oral food challenges
UR - http://www.scopus.com/inward/record.url?scp=85132294565&partnerID=8YFLogxK
U2 - 10.1186/s13223-022-00694-y
DO - 10.1186/s13223-022-00694-y
M3 - Letter/short communication
C2 - 35710451
SN - 1710-1484
VL - 18
SP - 54
JO - Allergy, Asthma and Clinical Immunology
JF - Allergy, Asthma and Clinical Immunology
IS - 1
M1 - 54
ER -